Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice

BACKGROUND: In clinical practice, the effect of durvalumab and radiation pneumonitis (RP) on survival after intensity-modulated radiotherapy (IMRT) is not fully understood. The purpose of this retrospective study was to investigate factors related to distant metastasis-free survival (DMFS), progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Takaya, Tsukita, Yoko, Katagiri, Yu, Matsushita, Haruo, Umezawa, Rei, Ishikawa, Yojiro, Takahashi, Noriyoshi, Suzuki, Yu, Takeda, Kazuya, Miyauchi, Eisaku, Saito, Ryota, Katsuta, Yoshiyuki, Kadoya, Noriyuki, Jingu, Keiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981776/
https://www.ncbi.nlm.nih.gov/pubmed/35379201
http://dx.doi.org/10.1186/s12885-022-09354-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981776/
https://www.ncbi.nlm.nih.gov/pubmed/35379201
http://dx.doi.org/10.1186/s12885-022-09354-1

Ejemplares similares